Table 1.
Antibody | Groupa | Contact with N501 | Structure | References | Neutralization (IC50, µg/ml, mean)b | Affinity (KD, nM, mean)c | ||||
---|---|---|---|---|---|---|---|---|---|---|
WT | N501Y | FCd | WT | N501Y | FCd | |||||
P2C-1F11 | Class 1 | No | PDB: 7CDI | Ge et al. [13] | 0.0300 | 0.0180 | 0.60 | 0.526 | 0.241 | 0.46 |
REGN10933 | Class 1 | No | PDB: 6XDG | Hansen, et al.[3] | 0.0015 | 0.0035 | 2.36 | 0.0645 | 0.123 | 1.91 |
CB6 | Class 1 | Yes | PDB: 7C01 | Shi et al. [1] | 0.0456 | 0.3363 | 7.38 | 0.321 | 2.14 | 6.67 |
BD-23 | Class 2 | Yes | PDB: 7BYR | Cao et al. [21] | 16.3052 | 2.4771 | 0.15 | 137 | 20.6 | 0.15 |
P2B-2F6 | Class 2 | No | PDB: 7BWJ | Ju et al. [2] | 0.1644 | 0.0697 | 0.42 | 0.667 | 0.267 | 0.40 |
P2C-1A3 | Class 2 | No | PDB: 7CDJ | Ge et al. [13] | 0.1862 | 0.2833 | 1.52 | 0.247 | 0.167 | 0.68 |
BD-368–2 | Class 2 | No | PDB: 7CHH | Du et al. [15] | 0.0004 | 0.0008 | 2.11 | 0.0649 | 0.0368 | 0.57 |
S309 | Class 3 | No | PDB: 6WPS | Pinto et al. [17] | 0.1641 | 0.4307 | 2.62 | < 0.001 | < 0.001 | n.a.e |
REGN10987 | Class 3 | No | PDB: 6XDG | Hansen, et al.[3] | 0.0062 | 0.0039 | 0.63 | 0.108 | 0.0587 | 0.54 |
EY6A | Class 4 | No | PDB: 6ZDH | Zhou et al. [16] | 7.0680 | 10.7957 | 1.53 | 0.111 | 0.134 | 1.21 |
COV2-2196 | n.a | n.a | n.a | Zost et al. [4] | 0.0032 | 0.0029 | 0.93 | 0.0681 | 0.0581 | 0.85 |
CV07-287 | n.a | n.a | n.a | Kreye et al. [5] | 0.2930 | 0.2610 | 0.89 | 1.19 | 1.25 | 1.05 |
aAntibodies were classified into four groups based on their competitions with ACE2 and recognitions with ‘up’/‘down’ conformations of RBD [12]
bNeutralization was measured as IC50 in µg/ml of nAbs against SARS-CoV-2 pseudovirus
cAffinity was measured as KD in nM of nAbs binding to SARS-CoV-2 RBD by SPR
dFC, Fold change. N501Y/WT
en.a., not available